Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic potential of pyruvate therapy for mitochondrial diseases.

Literature DB >> 17881297

Therapeutic potential of pyruvate therapy for mitochondrial diseases.

Masashi Tanaka, Yutaka Nishigaki, Noriyuki Fuku, Tohru Ibi, Ko Sahashi, Yasutoshi Koga.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2007 PMID： 17881297 DOI： 10.1016/j.mito.2007.07.002

Source DB: PubMed Journal: Mitochondrion ISSN： 1567-7249 Impact factor: 4.160

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction.

Authors: William C Hallows; Wei Yu; Brian C Smith; Mark K Devries; Mark K Devires; James J Ellinger; Shinichi Someya; Michael R Shortreed; Tomas Prolla; John L Markley; Lloyd M Smith; Shimin Zhao; Kun-Liang Guan; John M Denu
Journal: Mol Cell Date: 2011-01-21 Impact factor: 17.970

Review 2. Therapeutic potential of pyruvate therapy for patients with mitochondrial diseases: a systematic review.

Authors: Min Li; Shuang Zhou; Chaoyang Chen; Lingyun Ma; Daohuang Luo; Xin Tian; Xiu Dong; Ying Zhou; Yanling Yang; Yimin Cui
Journal: Ther Adv Endocrinol Metab Date: 2020-07-09 Impact factor: 3.565

3. Treatment of a citrin-deficient patient at the early stage of adult-onset type II citrullinaemia with arginine and sodium pyruvate.

Authors: K Mutoh; K Kurokawa; K Kobayashi; T Saheki
Journal: J Inherit Metab Dis Date: 2008-10-29 Impact factor: 4.982

4. Slc25a12 disruption alters myelination and neurofilaments: a model for a hypomyelination syndrome and childhood neurodevelopmental disorders.

Authors: Takeshi Sakurai; Nicolas Ramoz; Marta Barreto; Mihaela Gazdoiu; Nagahide Takahashi; Michael Gertner; Nathan Dorr; Miguel A Gama Sosa; Rita De Gasperi; Gissel Perez; James Schmeidler; Vivian Mitropoulou; H Carl Le; Mihaela Lupu; Patrick R Hof; Gregory A Elder; Joseph D Buxbaum
Journal: Biol Psychiatry Date: 2009-12-16 Impact factor: 13.382

Review 5. Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial diseases.

Authors: Kei Murayama; Masaru Shimura; Zhimei Liu; Yasushi Okazaki; Akira Ohtake
Journal: J Hum Genet Date: 2018-11-21 Impact factor: 3.172

6. Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF-10A benign breast epithelial cells.

Authors: Millie A Behera; Qunsheng Dai; Rachana Garde; Carrie Saner; Emily Jungheim; Thomas M Price
Journal: Am J Physiol Endocrinol Metab Date: 2009-08-18 Impact factor: 4.310

Therapeutic potential of pyruvate therapy for mitochondrial diseases.

1. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction.

Review 2. Therapeutic potential of pyruvate therapy for patients with mitochondrial diseases: a systematic review.

3. Treatment of a citrin-deficient patient at the early stage of adult-onset type II citrullinaemia with arginine and sodium pyruvate.

4. Slc25a12 disruption alters myelination and neurofilaments: a model for a hypomyelination syndrome and childhood neurodevelopmental disorders.

Review 5. Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial diseases.

6. Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF-10A benign breast epithelial cells.

7. Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure?

Review 8. Dysfunctional mitochondrial bioenergetics and the pathogenesis of hepatic disorders.

9. Role of inflammation and oxidative stress in the etiology of primary ovarian insufficiency.

10. Phenylbutyrate therapy for pyruvate dehydrogenase complex deficiency and lactic acidosis.